Catheter-directed thrombolysis is not limited to acute limb ischemia treatment: experience from a division of vascular surgery
- 1 March 2020
- journal article
- research article
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 61 (2) , 200-207
Abstract
BACKGROUND: Thrombolytic treatment has many potential indications in the era of modem vascular surgery. We aimed to analyze the contemporary experience in the catheter-directed, intraarterial thrombolysis in different clinical scenarios. METHODS: The available data of 121 patients with different types (acute, subacute, complications of vascular procedures) of lower limb ischemia treated by means of the intraarterial, catheter-directed thrombolysis between November 2011 and December 2016 were retrospectively analyzed. The basic treatment protocol, utilized in 92% of patients, was a catheter-directed infusion of 40 mg of alteplase within 3.5 hours. Pre- and intraprocedural factors (indications, demographic details, comorbidities, the dose of alteplase utilized, underlying lesions procedures), as well as postoperative outcomes (lysis grade, death, complications, reinterventions, and limb loss after 1-month observation), were analyzed. RESULTS: Successful thrombolysis was achieved in 76.1% (92 of 121) patients. The success rate was similar for acute, subacute limb ischemia and thrombotic complications of vascular procedures. Around 67.8% of patients (N.=82) had procedures to correct underlying lesions performed. Overall complication rate was 28.1%, but the major bleeding was observed in only 5% (6 patients). Neither intracranial bleeding nor gastrointestinal bleeding occurred. No mortality, 1.7% reintervention rate and 10.7% amputation rate were recorded during one-month follow-up. CONCLUSIONS: Accelerated intraarterial thrombolysis is an effective measure in the treatment of acute, sub-acute limb ischemia as well as thromboembolic complications of vascular procedures. It carries a low risk of major bleeding. The location of thrombus in the crural arteries adversely affects the treatment results. Atrial fibrillation increases the risk of amputation while complete thrombus lysis is protective.Keywords
This publication has 19 references indexed in Scilit:
- Outcomes of accelerated catheter-directed thrombolysis in patients with acute arterial thrombosisVascular Medicine, 2016
- Safety and Efficacy of Ultra-high-dose, Short-term Thrombolysis with rt-PA for Acute Lower Limb IschemiaEuropean Journal of Vascular and Endovascular Surgery, 2013
- Treatment of infrainguinal thromboembolic complications during peripheral endovascular procedures with AngioJet rheolytic thrombectomy, intraoperative thrombolysis, and selective stentingJournal of Vascular Surgery, 2012
- Thrombolysis for native arterial occlusions of the lower extremities: Clinical outcome and costJournal of Vascular Surgery, 2001
- A Comparison of Recombinant Urokinase with Vascular Surgery as Initial Treatment for Acute Arterial Occlusion of the LegsNew England Journal of Medicine, 1998
- Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE TrialAnnals of Surgery, 1994
- Percutaneous Intraarterial Thrombolysis: Analysis of Factors Affecting OutcomeJournal of Vascular and Interventional Radiology, 1994
- Fibrinolytic treatment of residual thrombus after catheter embolectomy for severe lower limb ischemiaJournal of Vascular Surgery, 1989
- Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy.Radiology, 1987
- Selective Clot Lysis with Low-Dose StreptokinaseRadiology, 1974